Company Filing History:
Years Active: 2006
Title: Innovations of José Manuel Sanchez Morgado in Vaccine Development
Introduction
José Manuel Sanchez Morgado is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of vaccine development through his innovative research and patents. His work focuses on the use of recombinant defective viral genomes to enhance immune responses against infectious agents.
Latest Patents
One of his key patents is titled "Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines." This patent describes vectors that comprise a recombinant defective viral genome expressing at least one antigen suitable for inducing systemic and secretory immune responses. The vectors are designed to be used in the formulation of vaccines, particularly for various animal species, including pigs, dogs, and cats. The defective viral genome relies on a helper virus for replication and encapsidation, making it a versatile tool in vaccine manufacturing.
Career Highlights
José Manuel Sanchez Morgado is currently associated with Cyanamid Iberica, S.A., where he continues to advance his research in vaccine technology. His work has the potential to significantly impact veterinary medicine and public health by providing effective solutions against infectious diseases.
Collaborations
He has collaborated with esteemed colleagues such as Luis Enjuanes Sanchez and Juan Plana Duran, contributing to a rich environment of innovation and research in his field.
Conclusion
José Manuel Sanchez Morgado's contributions to vaccine development through his innovative patents highlight the importance of research in combating infectious diseases. His work exemplifies the intersection of science and technology in improving health outcomes for both animals and humans.